Literature DB >> 7859377

Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid.

R M Pascale1, M M Simile, M R De Miglio, A Nufris, L Daino, M A Seddaiu, P M Rao, S Rajalakshmi, D S Sarma, F Feo.   

Abstract

Chemoprevention of liver carcinogenesis by S-adenosyl-L-methionine (SAM) was studied in F344 male rats. The rats were given 1,2-dimethylhydrazine (1,2-DMH) 2 HCl (100 mg/kg, i.p.) 18 h after two-thirds hepatectomy. One week later they were fed a semisynthetic basal diet containing 1% orotic acid (OA) for 29 weeks. At this time the rats were transferred to the basal semisynthetic diet and were killed 3 weeks later. SAM treatment (384 mumol/kg/day, i.m.), was started 1 week after 1,2-DMH and was continued up to the end of the experiment. Controls received solvent alone. SAM exerted an inhibitory effect on the induction of preneoplastic and neoplastic lesions. For example, nodules with diameters of 1-2 and 2-6 mm exhibited a decrease in both incidence and number per liver, while no such inhibitory effect was seen in the category of larger nodules. Furthermore, hepatocellular carcinoma (HCC) also exhibited a decrease in the SAM-treated group. The number/liver and incidence were 0.04 and 4.8% respectively in the SAM-treated group, compared to 0.38 and 37.8% in the control group. Microscopic examination showed the presence of well-differentiated carcinomas and atypical nodules in control rats, while only one small, well-differentiated tumor and one nodule with patterns of initial transformation were seen in SAM-treated rats. No patchy staining of glutathione-S-transferase, indicative of remodeling, was observed in nodules of both SAM-treated and control rats. Nodules and HCCs developing in SAM-treated rats exhibited a relatively high number of apoptotic bodies. Apoptotic bodies count showed 2.8- and 1.8-fold increases in nodules and HCCs of SAM-treated rats with respect to controls. These results indicate that SAM exerts a chemopreventive effect on hepatocarcinogenesis induced by the OA model. SAM seems to be more effective in inhibiting nodule to HCC progression than on the growth of nodule per se. The inhibitory effect is associated with an increase in cell loss by apoptosis in nodules and HCC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7859377     DOI: 10.1093/carcin/16.2.427

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  26 in total

Review 1.  SAMe and HuR in liver physiology: usefulness of stem cells in hepatic differentiation research.

Authors:  Laura Gomez-Santos; Mercedes Vazquez-Chantada; Jose Maria Mato; Maria Luz Martinez-Chantar
Journal:  Methods Mol Biol       Date:  2012

2.  S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers.

Authors:  Maria Lauda Tomasi; Ivan Tomasi; Komal Ramani; Rosa Maria Pascale; Jun Xu; Pasquale Giordano; José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

Review 3.  Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.

Authors:  Lauren Y Maldonado; Diana Arsene; José M Mato; Shelly C Lu
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-15

4.  Mutations in the S-Adenosylmethionine Synthetase Genes SAM1 and SAM2 Differentially Affect Genome Stability in Saccharomyces cerevisiae.

Authors:  Kellyn M Hoffert; Kathryn S P Higginbotham; Justin T Gibson; Stuart Oehrle; Erin D Strome
Journal:  Genetics       Date:  2019-07-18       Impact factor: 4.562

5.  MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.

Authors:  Heping Yang; Michele E Cho; Tony W H Li; Hui Peng; Kwang Suk Ko; Jose M Mato; Shelly C Lu
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

6.  S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model.

Authors:  Shelly C Lu; Komal Ramani; Xiaopeng Ou; Mark Lin; Victor Yu; Kwangsuk Ko; Ryan Park; Teodoro Bottiglieri; Hidekazu Tsukamoto; Gary Kanel; Samuel W French; José M Mato; Rex Moats; Edward Grant
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

Review 7.  Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment.

Authors:  Giuseppe Castello; Susan Costantini; Stefania Scala
Journal:  J Transl Med       Date:  2010-11-03       Impact factor: 5.531

Review 8.  S-adenosylmethionine in liver health, injury, and cancer.

Authors:  Shelly C Lu; José M Mato
Journal:  Physiol Rev       Date:  2012-10       Impact factor: 37.312

9.  A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma.

Authors:  Covadonga Huidobro; Estela G Toraño; Agustín F Fernández; Rocío G Urdinguio; Ramón M Rodríguez; Cecilia Ferrero; Pablo Martínez-Camblor; Loreto Boix; Jordi Bruix; Juan Luís García-Rodríguez; Marta Varela-Rey; José María Mato; María Luz Martínez-Chantar; Mario F Fraga
Journal:  J Mol Med (Berl)       Date:  2013-03-12       Impact factor: 4.599

Review 10.  S-Adenosylmethionine in cell growth, apoptosis and liver cancer.

Authors:  Shelly C Lu; José M Mato
Journal:  J Gastroenterol Hepatol       Date:  2008-03       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.